| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $44.2M | -2.7% | -21.9% |
| Cost of Revenue | $22.9M | -4.9% | -26.8% |
| Gross Profit | $21.3M | -0.2% | -16.0% |
| R&D Expense | $4.5M | +9.8% | +8.8% |
| SG&A Expense | $26.7M | -0.6% | -29.0% |
| Operating Income | -$9.9M | -2.9% | +39.5% |
| Pre-tax Income | -$6.5M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $255.8M | +5.1% | +472.7% |
| Short-term Investments | $165.5M | -9.3% | -27.4% |
| Accounts Receivable | $34.9M | +4.5% | -19.7% |
| Inventory | $23.3M | +1.3% | -1.0% |
| Current Assets | $484.8M | -0.9% | +38.4% |
| Total Assets |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$9.5M | — | — |
| Capital Expenditures | $11.0M | — | — |
| Investing Cash Flow | $250.3M | — | — |
| Financing Cash Flow | -$18.9M | — | — |
| Free Cash Flow | -$20.5M | — | — |
| +44.4% |
| -549.2% |
| Income Tax | $165K | -39.8% | -74.6% |
| Net Income | -$6.9M | -106.6% | -962.5% |
| EPS (Basic) | -$0.18 | -108.8% | -800.0% |
| EPS (Diluted) | -$0.18 | -108.8% | -800.0% |
| $774.3M |
| +0.1% |
| +10.3% |
| Current Liabilities | $30.7M | +2.0% | -50.0% |
| Total Liabilities | $261.1M | +1.0% | -7.8% |
| Stockholders' Equity | $513.3M | -0.4% | +22.6% |